ARCHIVES

FDA Faces Severe Regulatory, Scientific Needs, Report Finds.

This article is from The Cancer Letter archive.

Vol. 34 No. 04 | February 1, 2008

Download PDF Visit The Full Archive

Related Articles

DRCCA Board Okays Chemoprevention RFA, Referral Guidelines

January 29, 1982

Utah, NIEHS Report Finding BRACA1 Gene For Familial Breast, Ovarian Cancer

September 23, 1994

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

May 24, 1996

NCCS Networker Volume 3 Issue 2, Spring 1989

April 13, 1989

House Committee Begins Investigation Of NCI’s National Lung Screening Trial.

October 26, 2007

CTI Files Appeal Over FDA’s Decision on Pixantrone

December 3, 2010